Cross Country Healthcare Files 8-K

Ticker: CCRN · Form: 8-K · Filed: 2024-08-21T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, regulatory-filing, financial-statements

Related Tickers: CCRH

TL;DR

CCRH filed an 8-K for Reg FD and exhibits. Nothing major disclosed in this snippet.

AI Summary

On August 21, 2024, Cross Country Healthcare, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard regulatory filing.

Why It Matters

This filing indicates Cross Country Healthcare is making a regulatory disclosure and filing financial documents, which is standard practice for public companies.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain information that would immediately suggest significant risk.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided excerpt does not specify the content of the Regulation FD disclosure, only that it is being filed.

What financial statements and exhibits are being filed?

The excerpt states that financial statements and exhibits are being filed, but does not list their specific contents.

Has Cross Country Healthcare, Inc. changed its name or former address recently?

The filing indicates 'Not Applicable' for former name or address changes since the last report.

What is the company's principal executive office address?

The company's principal executive office is located at 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487.

What is the company's fiscal year end?

The company's fiscal year ends on December 31st.

From the Filing

0001628280-24-038030.txt : 20240821 0001628280-24-038030.hdr.sgml : 20240821 20240821162416 ACCESSION NUMBER: 0001628280-24-038030 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240821 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240821 DATE AS OF CHANGE: 20240821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 241229018 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 ccrn-20240821.htm 8-K ccrn-20240821 0001141103 FALSE 0001141103 2024-08-21 2024-08-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 21, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6551 Park of Commerce Boulevard, N.W. , Boca Raton , FL 33487 (Address of Principal Executive Office) (Zip Code) ( 561 ) 998-2232 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act:     Title of each class                 Trading Symbol         Name of each exchange on which registered Common stock, par value $0.0001 per share          CCRN              The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01    Regulation FD Disclosure. On August 21, 2024, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#822

View on Read The Filing